Insights into congenital stationary night blindness based on the structure of G90D rhodopsin. (12th April 2013)

• Record Type: Journal Article
• Authors: Singhal, Ankita; Ostermaier, Martin K; Vishnivetskiy, Sergey A; Panneels, Valérie; Homan, Kristoff T; Tesmer, John J G; Veprintsev, Dmitry; Deupi, Xavier; Gurevich, Vsevolod V; Schertler, Gebhard F X; Standfuss, Joerg
• Is Part Of: EMBO reports. Volume 14:Number 6(2013)
• Page Start: 520
• Page End: 526
• Publication Date: 2013-04-12
• Subjects: G protein‐coupled receptors -- biased signalling -- rhodopsin -- congenital stationary night blindness -- retinitis pigmentosa; Molecular biology -- Periodicals; Molecular Biology -- Periodicals; Molecular biology; Periodicals; 572.8
• DOI: 10.1038/embor.2013.44
• Languages: English
• ISSNs: 1469-221X

Abstract

Abstract : We present active‐state structures of the G protein‐coupled receptor (GPCRs) rhodopsin carrying the disease‐causing mutation G90D. Mutations of G90 cause either retinitis pigmentosa (RP) or congenital stationary night blindness (CSNB), a milder, non‐progressive form of RP. Our analysis shows that the CSNB‐causing G90D mutation introduces a salt bridge with K296. The mutant thus interferes with the E113Q‐K296 activation switch and the covalent binding of the inverse agonist 11‐ cis ‐retinal, two interactions that are crucial for the deactivation of rhodopsin. Other mutations, including G90V causing RP, cannot promote similar interactions. We discuss our findings in context of a model in which CSNB is caused by constitutive activation of the visual signalling cascade. Insights into congenital stationary night blindness based on the structure of G90D rhodopsin: The G90D rhodopsin mutant causes congenital stationary night blindness. This study shows that the mutation interferes with the E113‐K296 activation switch, introduces an alternative salt‐bridge and thus promotes the constant basal activation of the visual signal cascade typical for this disease.